Form 4: Ameren SVP Sells Shares Under 10b5-1 Plan

Theresa A. Shaw, SVP and CATO of Ameren Corp, reported a sale of 325 shares of common stock at $111.89 per share, executed under a pre-arranged 10b5-1 plan.

Summary

• Theresa A. Shaw, Senior Vice President and Chief Administrative Officer (SVP and CATO) of Ameren Corp (AEE), reported a transaction involving the company's common stock.
• On February 17, 2026, Shaw disposed of 325 shares of Ameren Corp common stock.
• The shares were sold at a price of $111.89 per share.
• This transaction was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this sale, Shaw directly beneficially owns 35,693 shares of Ameren Corp common stock.
• Additionally, Shaw holds an estimated 895 share equivalents indirectly through the Ameren Corporation Savings Investment Plan's unitized stock fund as of January 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which typically does not indicate a change in fundamental company sentiment.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a discretionary one, which often mitigates concerns about insider sentiment.

Negatives

• An insider sale, even if pre-planned, reduces the direct equity stake of a senior executive in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that routine insider transactions, particularly those executed under Rule 10b5-1 plans, are common across all industries, including the utilities sector where Ameren operates. These sales are typically pre-scheduled and do not necessarily reflect a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares by a senior executive under a 10b5-1 plan is unlikely to have a significant direct impact on the broader shareholder base or the company's stock price.

Key Dates

Recommendation

The filing details a routine insider stock sale executed under a pre-arranged 10b5-1 plan. This type of transaction is generally not indicative of new material information or a change in the company's fundamental outlook. Therefore, it does not provide a basis for a change in investment recommendation, suggesting a 'hold' position for existing investors.

Keywords

Ameren Corp, AEE, Theresa A. Shaw, Insider Trading, Form 4, 10b5-1 Plan, Stock Sale, Executive Compensation